Listen "It's Time to Flip the Script on Blood Testing"
Episode Synopsis
In this episode of Let's Talk Medtech, Babson Diagnostics CEO David Stein discusses the company's progress toward commercialization. Babson has developed a model for diagnostic blood testing that maintains a high standard of accuracy, yet requires only one-tenth the sample size of traditional venipuncture methods. Babson also uses a proprietary blood collection device to collect the sample at a participating pharmacy, then the sample is processed back at Babson's labs.
More episodes of the podcast Let’s Talk Medtech
How Stereotaxis Is Making Its Mark in Surgical Robotics: A Journey from Survival to Success
01/12/2025
Audacity Drives Innovation in Medtech
03/11/2025
Medtech Industry Health Check: Tariff Impacts, Hot Segments, and the Rise of Mid-Tier Companies
12/10/2025
Building a Stronger & Better AngioDynamics
02/09/2025
Medical Device Industry Mid-Year Trends 2025
18/08/2025
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.